引用本文:李受南,冼 磊,吴正球,张瑜红,雷敬富,卢强昌,阳 诺,胡 松.TCF21与Caspase-3在非小细胞肺癌组织中的表达及意义[J].中国临床新医学,2016,9(4):310-312.
【打印本页】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 1516次   下载 1317 本文二维码信息
码上扫一扫!
分享到: 微信 更多
TCF21与Caspase-3在非小细胞肺癌组织中的表达及意义
李受南,冼 磊,吴正球,张瑜红,雷敬富,卢强昌,阳 诺,胡 松
530405 广西,宾阳县人民医院胸外科(李受南,吴正球,雷敬富,卢强昌);530021 南宁,广西医科大学第一附属医院心胸外科(冼 磊,张瑜红,阳 诺,胡 松)
摘要:
[摘要] 目的 探讨TCF21与Caspase-3在非小细胞肺癌(NSCLC)组织中的表达及意义。方法 收集广西宾阳县人民医院2013-01~2015-01外科手术切除的NSCLC标本共44例(含癌及癌旁组织)。采用实时荧光定量PCR(RT-PCR)技术检测TCF21与Caspase-3在肺癌组织及正常组织中的表达,分析NSCLC组织中TCF21与Caspase-3的表达及与临床分期的关系。结果 TCF21和Caspase-3在NSCLC组织中表达明显低于癌旁正常肺组织[(0.36±0.70) vs (1.00±0.00)、(0.62±0.56) vs (1.00±0.00),P<0.01],且二者在肺癌TNM Ⅲ期中的表达较Ⅰ+Ⅱ期的表达量明显降低[(0.05±0.06) vs (0.48±0.79)、(0.17±0.20) vs (0.78±0.56),P<0.01]。TCF21和Caspase-3在NSCLC组织中的表达呈正相关。结论 TCF21和Caspase-3低表达可能促进了肿瘤的恶性增殖及转移,联合检测TCF21和Caspase-3对判断NSCLC恶性程度、转移潜能及预后有重要的临床意义。
关键词:  转录因子21  Caspase-3  非小细胞肺癌  凋亡
DOI:10.3969/j.issn.1674-3806.2016.04.11
分类号:R 734
基金项目:南宁市科研项目(编号:20133195)
The expressions of TCF21 and Caspase-3 and their clinical significances in non-small cell lung cancer
LI Shou-nan, XIAN Lei, WU Zheng-qiu, et al.
Department of Cardiothoracic Surgery, the People′s Hospital of Binyang County, Guangxi 530405, China
Abstract:
[Abstract] Objective To investigate the relationship between the expressions of TCF21 and Caspase-3 and the clinicopathological features in non-small cell lung cancer(NSCLC).Methods 44 samples coming from both adjacent and cancer tissues were collected from the People′s Hospital of Binyang County in Guangxi during 2013 to 2015. Real-time PCR(RT-PCR) was used to assay the expressions of TCF21 and Caspase-3 in lung cancer and normal tissues, and the relationship between the expressions of TCF21 and Caspase-3 and the clinicopathological features in NSCLC was analyzed.Results The expressions of TCF21 and Caspase-3 in NSCLC tissues were significantly lower than those in the matched normal lung tissues[(0.36±0.70) vs (1.00±0.00), (0.62±0.56) vs (1.00±0.00), P<0. 05]. The levels of TCF21 and Caspase-3 expressions were significantly lower in the mid-term lung cancer TNM Ⅲ than those in TNM Ⅰ+Ⅱ[(0.05±0.06) vs (0.48±0.79), (0.17±0.20) vs (0.78±0.56), P<0.01]. There was a positive correlation between the expressions of TCF21 and Caspase-3 in NSCLC. Conclusion  The low expressions of TCF21 and Caspase-3 may aggravate the malignant hyperplasy and metastasis of tumor, combined detection of the expressions of TCF21 and Caspase-3 plays an important role in evaluating the degree of malignancy, and predicting the potential metastasis and prognosis of NSCLC.
Key words:  Transcription factor 21(TCF21)  Caspase-3  Non-small cell lung cancer(NSCLC)  Apoptosis